G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -33.3% | 842 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | -18.2% | 842 | 0.0% | 0.00% | – |
| Q3 2021 | $11,000 | -38.9% | 842 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | -10.0% | 842 | 0.0% | 0.00% | – |
| Q1 2021 | $20,000 | 0.0% | 842 | -23.5% | 0.00% | – |
| Q4 2020 | $20,000 | +53.8% | 1,100 | 0.0% | 0.00% | – |
| Q3 2020 | $13,000 | -51.9% | 1,100 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | +125.0% | 1,100 | +83.3% | 0.00% | – |
| Q4 2017 | $12,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |